This hypothesis proposes that rationally engineered analogs of kisspeptin-13 (KP-13) can retain KISS1R agonist activity while demonstrating improved metabolic stability and prolonged signaling duration compared to the native peptide.
Vladimir Demidov
Research Lead
Therapeutic Relevance
KISS1R is biologically relevant for reproduction, but no data validates the proposed mechanism.
Therapeutic Optionality
KISS1R role is narrow, mainly reproductive endocrinology with limited broader flexibility.
Intellectual Property
Analog engineering approach is reasonable but peptide modifications are well-known in prior art.